NCT07023172View on ClinicalTrials.gov

Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablets

Not yet recruitingOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions

Type 2 Diabetes

Trial Locations (1)

210000

Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing

All Listed Sponsors

lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER